A citation-based method for searching scientific literature

Gabriella Misso, Maria Teresa Di Martino, Giuseppe De Rosa, Ammad Ahmad Farooqi, Angela Lombardi, Virginia Campani, Mayra Rachele Zarone, Annamaria Gullà, Pierosandro Tagliaferri, Pierfrancesco Tassone, Michele Caraglia. Mol Ther Nucleic Acids 2014
Times Cited: 341







List of co-cited articles
693 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




The miR-34 family in cancer and apoptosis.
H Hermeking. Cell Death Differ 2010
892
17

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.
Muhammad S Beg, Andrew J Brenner, Jasgit Sachdev, Mitesh Borad, Yoon-Koo Kang, Jay Stoudemire, Susan Smith, Andreas G Bader, Sinil Kim, David S Hong. Invest New Drugs 2017
419
15

Alternative mechanisms of miR-34a regulation in cancer.
Eva Slabáková, Zoran Culig, Ján Remšík, Karel Souček. Cell Death Dis 2017
122
14

A microRNA component of the p53 tumour suppressor network.
Lin He, Xingyue He, Lee P Lim, Elisa de Stanchina, Zhenyu Xuan, Yu Liang, Wen Xue, Lars Zender, Jill Magnus, Dana Ridzon,[...]. Nature 2007
13


MicroRNA-34a: a potential therapeutic target in human cancer.
X J Li, Z J Ren, J H Tang. Cell Death Dis 2014
199
12

PDL1 Regulation by p53 via miR-34.
Maria Angelica Cortez, Cristina Ivan, David Valdecanas, Xiaohong Wang, Heidi J Peltier, Yuping Ye, Luiz Araujo, David P Carbone, Konstantin Shilo, Dipak K Giri,[...]. J Natl Cancer Inst 2015
324
11

The p53/miR-34 axis in development and disease.
Matjaz Rokavec, Huihui Li, Longchang Jiang, Heiko Hermeking. J Mol Cell Biol 2014
202
11

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer.
Lu Zhang, Yi Liao, Liling Tang. J Exp Clin Cancer Res 2019
124
11

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Can Liu, Kevin Kelnar, Bigang Liu, Xin Chen, Tammy Calhoun-Davis, Hangwen Li, Lubna Patrawala, Hong Yan, Collene Jeter, Sofia Honorio,[...]. Nat Med 2011
10



miR-34: from bench to bedside.
Massimiliano Agostini, Richard A Knight. Oncotarget 2014
184
9

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Tsung-Cheng Chang, Erik A Wentzel, Oliver A Kent, Kalyani Ramachandran, Michael Mullendore, Kwang Hyuck Lee, Georg Feldmann, Munekazu Yamakuchi, Marcella Ferlito, Charles J Lowenstein,[...]. Mol Cell 2007
9

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
David S Hong, Yoon-Koo Kang, Mitesh Borad, Jasgit Sachdev, Samuel Ejadi, Ho Yeong Lim, Andrew J Brenner, Keunchil Park, Jae-Lyun Lee, Tae-You Kim,[...]. Br J Cancer 2020
133
9


Oncomirs - microRNAs with a role in cancer.
Aurora Esquela-Kerscher, Frank J Slack. Nat Rev Cancer 2006
8

miR-34a repression of SIRT1 regulates apoptosis.
Munekazu Yamakuchi, Marcella Ferlito, Charles J Lowenstein. Proc Natl Acad Sci U S A 2008
987
8

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.
Dmitri Lodygin, Valery Tarasov, Alexey Epanchintsev, Carola Berking, Tatjana Knyazeva, Henrike Körner, Piotr Knyazev, Joachim Diebold, Heiko Hermeking. Cell Cycle 2008
593
7

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
Fang Sun, Hanjiang Fu, Qin Liu, Yi Tie, Jie Zhu, Ruiyun Xing, Zhixian Sun, Xiaofei Zheng. FEBS Lett 2008
371
7

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.
Maria Teresa Di Martino, Virginia Campani, Gabriella Misso, Maria Eugenia Gallo Cantafio, Annamaria Gullà, Umberto Foresta, Pietro Hiram Guzzi, Maria Castellano, Anna Grimaldi, Vincenzo Gigantino,[...]. PLoS One 2014
82
8

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.
Jason F Wiggins, Lynnsie Ruffino, Kevin Kelnar, Michael Omotola, Lubna Patrawala, David Brown, Andreas G Bader. Cancer Res 2010
490
7

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
Markus Vogt, Johanna Munding, Martha Grüner, Sven-Thorsten Liffers, Berlinda Verdoodt, Jennifer Hauk, Lars Steinstraesser, Andrea Tannapfel, Heiko Hermeking. Virchows Arch 2011
237
7

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.
Imran A Babar, Christopher J Cheng, Carmen J Booth, Xianping Liang, Joanne B Weidhaas, W Mark Saltzman, Frank J Slack. Proc Natl Acad Sci U S A 2012
333
7

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.
Nico van Zandwijk, Nick Pavlakis, Steven C Kao, Anthony Linton, Michael J Boyer, Stephen Clarke, Yennie Huynh, Agata Chrzanowska, Michael J Fulham, Dale L Bailey,[...]. Lancet Oncol 2017
265
7

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
Guido T Bommer, Isabelle Gerin, Ying Feng, Andrew J Kaczorowski, Rork Kuick, Robert E Love, Yali Zhai, Thomas J Giordano, Zhaohui S Qin, Bethany B Moore,[...]. Curr Biol 2007
857
6

MicroRNAs and other non-coding RNAs as targets for anticancer drug development.
Hui Ling, Muller Fabbri, George A Calin. Nat Rev Drug Discov 2013
887
6

Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.
Mayra Rachele Zarone, Gabriella Misso, Anna Grimaldi, Silvia Zappavigna, Margherita Russo, Evzen Amler, Maria Teresa Di Martino, Nicola Amodio, Pierosandro Tagliaferri, Pierfrancesco Tassone,[...]. Sci Rep 2017
29
20

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
Donato Cosco, Felisa Cilurzo, Jessica Maiuolo, Cinzia Federico, Maria Teresa Di Martino, Maria Chiara Cristiano, Pierfrancesco Tassone, Massimo Fresta, Donatella Paolino. Sci Rep 2015
71
8

Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.
Dipankar Pramanik, Nathaniel R Campbell, Collins Karikari, Raghu Chivukula, Oliver A Kent, Joshua T Mendell, Anirban Maitra. Mol Cancer Ther 2011
214
6

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
Laisheng Li, Linjin Yuan, Jinmei Luo, Jie Gao, Jiaoli Guo, Xiaoming Xie. Clin Exp Med 2013
214
6

Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer.
Christopher L Daige, Jason F Wiggins, Leslie Priddy, Terri Nelligan-Davis, Jane Zhao, David Brown. Mol Cancer Ther 2014
95
6

MicroRNA-34 family in breast cancer: from research to therapeutic potential.
Saber Imani, Ray-Chang Wu, Junjiang Fu. J Cancer 2018
36
16

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model.
Janaiah Kota, Raghu R Chivukula, Kathryn A O'Donnell, Erik A Wentzel, Chrystal L Montgomery, Hun-Way Hwang, Tsung-Cheng Chang, Perumal Vivekanandan, Michael Torbenson, K Reed Clark,[...]. Cell 2009
6

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.
Brian D Adams, Vikram B Wali, Christopher J Cheng, Sachi Inukai, Carmen J Booth, Seema Agarwal, David L Rimm, Balázs Győrffy, Libero Santarpia, Lajos Pusztai,[...]. Cancer Res 2016
93
6

miR-15 and miR-16 induce apoptosis by targeting BCL2.
Amelia Cimmino, George Adrian Calin, Muller Fabbri, Marilena V Iorio, Manuela Ferracin, Masayoshi Shimizu, Sylwia E Wojcik, Rami I Aqeilan, Simona Zupo, Mariella Dono,[...]. Proc Natl Acad Sci U S A 2005
6

Most mammalian mRNAs are conserved targets of microRNAs.
Robin C Friedman, Kyle Kai-How Farh, Christopher B Burge, David P Bartel. Genome Res 2009
6

MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Saber Imani, Chunli Wei, Jingliang Cheng, Md Asaduzzaman Khan, Shangyi Fu, Luquan Yang, Mousumi Tania, Xianqin Zhang, Xiuli Xiao, Xianning Zhang,[...]. Oncotarget 2017
60
10

MicroRNA signatures in human cancers.
George A Calin, Carlo M Croce. Nat Rev Cancer 2006
6

Treatment of HCV infection by targeting microRNA.
Harry L A Janssen, Hendrik W Reesink, Eric J Lawitz, Stefan Zeuzem, Maribel Rodriguez-Torres, Keyur Patel, Adriaan J van der Meer, Amy K Patick, Alice Chen, Yi Zhou,[...]. N Engl J Med 2013
6

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Na Li, Hanjiang Fu, Yi Tie, Zheng Hu, Wei Kong, Yongge Wu, Xiaofei Zheng. Cancer Lett 2009
339
5

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.
Maria T Di Martino, Emanuela Leone, Nicola Amodio, Umberto Foresta, Marta Lionetti, Maria R Pitari, Maria E Gallo Cantafio, Annamaria Gullà, Francesco Conforti, Eugenio Morelli,[...]. Clin Cancer Res 2012
178
5

In vivo delivery of miRNAs for cancer therapy: challenges and strategies.
Yunching Chen, Dong-Yu Gao, Leaf Huang. Adv Drug Deliv Rev 2015
349
5

Progress in microRNA delivery.
Yu Zhang, Zaijie Wang, Richard A Gemeinhart. J Control Release 2013
336
5

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.
Matjaz Rokavec, Meryem Gülfem Öner, Huihui Li, Rene Jackstadt, Longchang Jiang, Dmitri Lodygin, Markus Kaller, David Horst, Paul K Ziegler, Sarah Schwitalla,[...]. J Clin Invest 2014
421
5

A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer.
A L Kasinski, K Kelnar, C Stahlhut, E Orellana, J Zhao, E Shimer, S Dysart, X Chen, A G Bader, F J Slack. Oncogene 2015
137
5




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.